FindTrial
Sign In

Application of esketamine general anesthesia in pediatric urology under ERAS concept

Application of esketamine general anesthesia in pediatric urology under ERAS concept

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088426
Enrollment
Unknown
Registered
2024-08-19
Start date
2023-01-16
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

concealed penile correction surgery

Interventions

group esketamine:esketamine 0.3mg/kg/h continuous infusion
contral group:saline 0.3ug/kg/h continuous infusion

Sponsors

Jiaxing University Affiliated Women and Children Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
3 Years to 12 Years

Inclusion criteria

Inclusion criteria: ASA?~?;aged between 3 to 12 years old;children with concealed penis

Exclusion criteria

Exclusion criteria: hypertension, severe heart disease,coagulation dysfunction, upper respiratory tract infection, infection at the puncture site, low blood volume state

Design outcomes

Primary

MeasureTime frame
quality of extubation;—

Secondary

MeasureTime frame
side effects;—

Countries

China

Contacts

Public ContactXiaoxia Sun

Jiaxing University Affiliated Women and Children Hospital

echo1122.cool@163.com+86 188 6766 3096

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026